echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Radiology: Is the NIHSS score low in patients with acute ischemic stroke suitable for thrombosis therapy?

    Radiology: Is the NIHSS score low in patients with acute ischemic stroke suitable for thrombosis therapy?

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Objective The treatment of stroke patients with mild neurological dysfunction is controversialA recent study of ischemic stroke patients with rtPA treatment showed that patients benefited from rtPA treatment with outnumbered by randomized thrombolytic therapy and aspirin therapyThe purpose of this study was to evaluate the safety and value of thrombotic therapy in acute ischemic stroke patients with a low NIHSS score based on MRI screeningMethods Retrospective analysis of NIHSS database screening patients with NIHSS score of 5 and thrombolytic treatment within 4.5 hours after MRI screening and onsetAN MRI REVIEW WAS PERFORMED 24 HOURS AFTER THROMBOSIS TO ASSESS THE RISK OF CEREBRAL HAEMORRHAGEThe main results were symptomatic intracranial hemorrhage (sICH) and a good 90-day improved RS score (0-1)Subgroup analysis of patients suitable for PRISMS trials included patients withnoneurotic dysfunctionResults Of the 121 patients included, the median age was 65 years, the median NIHSS score was 3, and the female patients were 63%The conversion rate was 13%, of which 11% of patients were speckled bleedingsICH rate of 1%A total of 66 patients had 90 days of prognosis data, of which 74% had good resultsIn the subgroup analysis of 81 patients, no sICH appeared, and a total of 50 patients had 90 days of prognosis, of which 84% had a good prognosisConclusion The thrombolytic therapy in stroke patients with MRI-evaluated and mild neurodysfunction was safeLong-term research in this population will benefit from MRI screening
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.